Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:678514rdf:typepubmed:Citationlld:pubmed
pubmed-article:678514lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:678514lifeskim:mentionsumls-concept:C0085196lld:lifeskim
pubmed-article:678514lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:678514lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:678514lifeskim:mentionsumls-concept:C0024485lld:lifeskim
pubmed-article:678514lifeskim:mentionsumls-concept:C0028580lld:lifeskim
pubmed-article:678514lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:678514lifeskim:mentionsumls-concept:C0205198lld:lifeskim
pubmed-article:678514pubmed:issue12lld:pubmed
pubmed-article:678514pubmed:dateCreated1978-10-18lld:pubmed
pubmed-article:678514pubmed:abstractText6-Hydroxydopamine (I) is a well-known neurocytotoxic agent which has become an important tool in many neurochemical studies in recent years. Biochemical investigations of the mechanism of action of 6-hydroxydopamine indicated that this amine binds covalently and irreversibly to proteins. In the present work, molecular properties of 6-hydroxydopamine in aqueous solution such as self-association, ionization, intramolecular conformations, and possible cyclization were investigated using 1H nuclear magnetic resonance spectroscopy. A model study for the interaction of 6-hydroxydopamine with proteins was undertaken by using SH-containing molecules: cysteine, glutathione, and bovine serum albumin. The binding of these compounds to 6-hydroxydopamine was found to cause labilization of the hydrogen attached to C2 of the amine aromatic ring. This effect was interpreted in terms of nucleophilic attack of RS- on C1 of 6-hydroxydopamine. A proposed model for neurocytotoxicity is discussed.lld:pubmed
pubmed-article:678514pubmed:languageenglld:pubmed
pubmed-article:678514pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:678514pubmed:citationSubsetIMlld:pubmed
pubmed-article:678514pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:678514pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:678514pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:678514pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:678514pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:678514pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:678514pubmed:statusMEDLINElld:pubmed
pubmed-article:678514pubmed:monthJunlld:pubmed
pubmed-article:678514pubmed:issn0006-2960lld:pubmed
pubmed-article:678514pubmed:authorpubmed-author:GranotJJlld:pubmed
pubmed-article:678514pubmed:authorpubmed-author:RotmanAAlld:pubmed
pubmed-article:678514pubmed:issnTypePrintlld:pubmed
pubmed-article:678514pubmed:day13lld:pubmed
pubmed-article:678514pubmed:volume17lld:pubmed
pubmed-article:678514pubmed:ownerNLMlld:pubmed
pubmed-article:678514pubmed:authorsCompleteYlld:pubmed
pubmed-article:678514pubmed:pagination2370-4lld:pubmed
pubmed-article:678514pubmed:dateRevised2000-12-18lld:pubmed
pubmed-article:678514pubmed:meshHeadingpubmed-meshheading:678514-P...lld:pubmed
pubmed-article:678514pubmed:meshHeadingpubmed-meshheading:678514-S...lld:pubmed
pubmed-article:678514pubmed:meshHeadingpubmed-meshheading:678514-N...lld:pubmed
pubmed-article:678514pubmed:meshHeadingpubmed-meshheading:678514-C...lld:pubmed
pubmed-article:678514pubmed:meshHeadingpubmed-meshheading:678514-G...lld:pubmed
pubmed-article:678514pubmed:meshHeadingpubmed-meshheading:678514-S...lld:pubmed
pubmed-article:678514pubmed:meshHeadingpubmed-meshheading:678514-M...lld:pubmed
pubmed-article:678514pubmed:meshHeadingpubmed-meshheading:678514-M...lld:pubmed
pubmed-article:678514pubmed:meshHeadingpubmed-meshheading:678514-M...lld:pubmed
pubmed-article:678514pubmed:meshHeadingpubmed-meshheading:678514-H...lld:pubmed
pubmed-article:678514pubmed:year1978lld:pubmed
pubmed-article:678514pubmed:articleTitleNuclear magnetic resonance studies of 6-hydroxydopamine and its interactions with SH-containing model compounds. Evaluation of possible mechanism for neurocytotoxicity.lld:pubmed
pubmed-article:678514pubmed:publicationTypeJournal Articlelld:pubmed